$SGHT News

Last published 6d ago

6d agoSGHTSight Sciences to Present at Two Upcoming Investor ConferencesGlobeNewswireMENLO PARK, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
6d agoSGHTSight Sciences Announces CMS Establishment of a Practice Expense Supply Code for TearCare SmartLidsGlobeNewswireMENLO PARK, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing innovative,
1w agoSGHTSight Sciences, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 7.01 Item 9.01
1w agoSGHTSight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue GuidanceGlobeNewswireMENLO PARK, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
1w agoSGHTSight Sciences Third Quarter 2026 Earnings Results - SIGHT SCIENCES INCEarnings Call TranscriptsGood day and thank you for standing by. Welcome to the Site Sciences third quarter earnings results conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will
3w agoSGHTSight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026GlobeNewswireMENLO PARK, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
1mo agoSGHTSGHT - 1776476 - SIGHT SCIENCES INCEarnings Call TranscriptsAll right. Thank you, everybody, for joining. First, importantly, there's a disclaimer on the Morgan Stanley website that I encourage everybody to go to. With that, I'd like to welcome the Site Sciences team. We have Pau
1mo agoSGHTMorgan Stanley 24th Annual Global Healthcare Conference - SIGHT SCIENCES INCEarnings Call TranscriptsAll right. Thank you, everybody, for joining. First, importantly, there's a disclaimer on the Morgan Stanley website that I encourage everybody to go to. With that, I'd like to welcome the Site Sciences team. We have Pau
2mo agoSGHTSight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15GlobeNewswireMENLO PARK, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
2mo agoSGHTTearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye DiseaseGlobeNewswireMENLO PARK, Calif., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT), an eyecare technology company focused on developing and commercializing innovative interventional technologies intended to
3mo agoSGHTSight Sciences Reports Second Quarter 2026 Financial ResultsGlobeNewswireMENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
3mo agoSGHTSight Sciences Announces Aetna Coverage for OMNI and SION Surgical SystemsGlobeNewswireMENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
3mo agoSGHTSight Sciences Receives FDA 510(k) Clearance of the OMNI Ultra Surgical SystemGlobeNewswireMENLO PARK, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT), an eyecare technology company focused on developing and commercializing innovative interventional technologies intended to
3mo agoSGHTSight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026GlobeNewswireMENLO PARK, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
6mo agoSGHT2026 GLOBAL HEALTHCARE CONFERENCESIGHT SCIENCES INCEarnings Call TranscriptsGood afternoon. I'm Ray. I am part of the MedTech research team here at Bank of America, and it's my pleasure to introduce Paul Badawi from Sight Sciences here today. Welcome, Paul. Thanks for being here. All right. Well
6mo agoSGHTSight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue GuidanceGlobeNewswireMENLO PARK, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing
6mo agoSGHTSight Sciences to Present at Two Upcoming Investor ConferencesGlobeNewswireMENLO PARK, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
6mo agoSGHTSight Sciences Announces the Release of its Sustainability ReportGlobeNewswireMENLO PARK, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate
6mo agoSGHTSight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026GlobeNewswireMENLO PARK, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
7mo agoSGHTSight Sciences' Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual MeetingGlobeNewswireMENLO PARK, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences, or the Company), an eyecare company focused on developing and commercializing innovative, interventional
7mo agoSGHTSight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13thGlobeNewswireMENLO PARK, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative,
7mo agoSGHTSight Sciences Secures Order on Post-Trial Motions That Preserves the Jury's Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® MicrostentGlobeNewswireMENLO PARK, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
8mo agoSGHTSight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial GuidanceGlobeNewswireMENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing
8mo agoSGHTSight Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026GlobeNewswireMENLO PARK, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
10mo agoSGHTSight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial HighlightsGlobeNewswireMENLO PARK, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
1y agoSGHTNew Peer-Reviewed Publications Highlight Effectiveness of OMNI® Surgical System with TruSync™ Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African AmericansGlobeNewswireMENLO PARK, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences, or the Company), an eyecare company focused on developing and commercializing innovative, interventional
1y agoSGHTSight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial OfficerGlobeNewswireMENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing innovative,
1y agoSGHTSight Sciences to Present at Two Upcoming Investor ConferencesGlobeNewswireMENLO PARK, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
1y agoSGHTSight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025GlobeNewswireMENLO PARK, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
1y agoSGHTSight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare® Interventional Dry Eye ProcedureGlobeNewswireMENLO PARK, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
1y agoSGHTSight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI® Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication UseGlobeNewswireMENLO PARK, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
1y agoSGHTSight Sciences, Inc. (SGHT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)Earnings Call Transcripts
1y agoSGHTSight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare's® Expanded Coverage of Glaucoma Surgical TreatmentsGlobeNewswireMENLO PARK, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
1y agoSGHTSight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJOGlobeNewswireMENLO PARK, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company) an eyecare technology company focused on developing and commercializing innovative,
1y agoSGHTSight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare ConferenceGlobeNewswireMENLO PARK, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company) an eyecare technology company focused on developing and commercializing innovative,
1y agoSGHTSight Sciences, Inc. (SGHT) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
1y agoSGHTSight Sciences Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Revenue GuidanceGlobeNewswireMENLO PARK, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
1y agoSGHTSight Sciences Announces the Results of a Cost-Utility Analysis Demonstrating Cost Savings and Greater Health Utility with the TearCare® System Compared to Cyclosporine 0.05% for Treating Meibomian Gland Disease-Associated Dry Eye DiseaseGlobeNewswireMENLO PARK, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative technology
1y agoSGHTSight Sciences Announces the Publication of the 24-Month Results of the SAHARA RCT Demonstrating the Durability of the TearCare® Procedure for the Treatment of Dry Eye DiseaseGlobeNewswireMENLO PARK, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company) an eyecare technology company focused on developing and commercializing innovative technology
1y agoSGHTSight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025GlobeNewswireMENLO PARK, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative
1y agoSGHTSight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27thGlobeNewswireMENLO PARK, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,
1y agoSGHTSight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue GuidanceGlobeNewswireMENLO PARK, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to
1y agoSGHTSight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025GlobeNewswireMENLO PARK, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative,
1y agoSGHTSight Sciences Announces the Release of its Sustainability ReportGlobeNewswireMENLO PARK, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate
1y agoBWXT SGHTSight Sciences Appoints Gary Burbach to its Board of DirectorsGlobeNewswireMENLO PARK, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing innovative,
1y agoSGHTSight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product PortfolioGlobeNewswireMENLO PARK, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) , an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to
1y agoSGHTSight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8thGlobeNewswireMENLO PARK, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative,
1y agoSGHTSight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial GuidanceGlobeNewswireMENLO PARK, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing
1y agoSGHTSight Sciences to Present Comprehensive Clinical Data on the OMNI® Surgical System at the 2025 American Glaucoma Society Annual MeetingGlobeNewswireA Meta-Analysis of 22 Studies, and Data from the IRIS® Registry Highlighting Clinical Outcomes in Real-World Clinical Practice, Demonstrates Significant, Long-Term IOP Reduction and Medication Reduction with the
1y agoSGHTSight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025GlobeNewswireMENLO PARK, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative